跳至主要内容
临床试验/NCT04624685
NCT04624685Unknown不适用

iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study

Glaukos Corporation24 个研究点 分布在 1 个国家目标入组 475 人开始时间: 2020年1月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
475
试验地点
24
主要终点
iStent inject Placement and Stability

研究概览

简要总结

Long term follow up of subjects in the IDE study for iStent Inject to monitor safety

详细描述

To evaluate the long -term rate of clinically relevant complications associated with iStent inject® placement and stability in subjects who have completed participation of the IDE clinical trial (GC-008).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Randomized subject followed for 24 months in the GC-008 study
  • Able to understand study requirements
  • Willing to attend scheduled follow-up exams for 5 years post-operatively
  • Able and willing to provide written informed consent on the IRB approved Informed Consent Form

排除标准

  • 未提供

结局指标

主要结局

iStent inject Placement and Stability

时间窗: 60 Months

Rate of clinically relevant complications associated with iStent inject placement and stability.

次要结局

  • Sight-Threatening Adverse Events(60 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验